P275 Platinum compounds (PLcs) added to standard adjuvant or neoadjuvant regimen of doxorubicin plus cyclophosphamide (AC), followed by weekly paclitaxel (wP) in triple negative (TN), HER 2-neu positive (HER 2+) or locally advanced breast cancer (LABC)

Saved in:
Bibliographic Details
Published inBreast (Edinburgh) Vol. 20; p. S66
Main Authors Vassilaki, M, Sioulas, A, Tsantekidou, M, Klitsa, A, Desses, N, Georgakopoulos, C, Kosmidis, C, Tsionou, C, Parassiris, V, Xepapadakis, G
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 2011
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:0960-9776
1532-3080
DOI:10.1016/S0960-9776(11)70217-X